News about Manufacturing

China Approves GSK's Exdensur for Chronic Rhinosinusitis with Nasal Polyps

GSK plc has received approval from China’s National Medical Products Administration (NMPA) for Exdensur (depemokimab) as an add-on therapy for adult patients with Chronic Rhinosinusitis with Nasal Polyps who remain inadequately controlled with systemic corticosteroids or surgery.

Manufacturing | 09/04/2026 | By Darshana

Altruist Biologics Wins First Commercial Manufacturing License for Hangzhou Facility

Altruist Biologics secures its first GMP commercial manufacturing license for its Hangzhou facility, featuring four 20,000L bioreactors. Achieved in just two months, this milestone highlights strong technical expertise and global-quality standards.

Manufacturing | 09/04/2026 | By News Bureau |  102

Samsung Biologics Expands into US with GSK Facility Acquisition in Maryland

Samsung Biologics has completed the acquisition of a biologics manufacturing facility in Rockville, Maryland from GSK, marking its first manufacturing presence in the United States.

Manufacturing | 02/04/2026 | By Darshana |  105

Lilly to Acquire Centessa in USD 6.3 Billion Deal, Expands Neuroscience Pipeline

Eli Lilly and Company has announced a definitive agreement to acquire Centessa Pharmaceuticals plc, strengthening its neuroscience portfolio and advancing next-generation therapies for sleep-related and neurological disorders.

Manufacturing | 01/04/2026 | By Darshana

Eveliqure and Serum Institute of India Partner to Develop Anti-Diarrhoeal Vaccines

Eveliqure and Serum Institute of India (SII) have partnered to develop anti-diarrhoeal vaccines, with Eveliqure set to receive an upfront payment, milestone-based earnings and royalties on net sales, while SII will lead development and global commercialisation.

Manufacturing | 23/03/2026 | By News Bureau

AstraZeneca to Build Cell Therapy Hub and Innovation Centre in Shanghai

AstraZeneca has announced plans to set up a new cell therapy manufacturing and supply base along with an innovation centre in Shanghai, strengthening its presence in one of its key global markets.

Manufacturing | 20/03/2026 | By Darshana |  129

LGM Pharma Expands US Manufacturing, Invests USD 15 Million in Texas and Colorado

LGM Pharma has expanded its US manufacturing with a total USD 15 million investment across Texas and Colorado, boosting CDMO capacity for suppository, semi-solid and oral solid dose production while strengthening domestic supply chains for finished dosage manufacturing.

Manufacturing | 20/03/2026 | By News Bureau

Lupin Manufacturing Solutions Scales Up Dabhasa Manufacturing Facility

Lupin Manufacturing Solutions has expanded its Dabhasa facility with a new block and dedicated peptide manufacturing units, strengthening its CRDMO capabilities and boosting capacity for advanced pharma development and production.

Manufacturing | 19/03/2026 | By News Bureau |  104

Dr Jitendra Singh Lays Foundation for INR 600 Crore Orchid Pharma Project in J&K

Dr Jitendra Singh laid the foundation for an INR 600 crore multinational pharma manufacturing facility in Kathua, highlighting the region’s rising industrial potential and its role in strengthening India’s pharma exports and economic growth.

Manufacturing | 18/03/2026 | By Akanki |  112

Eli Lilly Commits USD 3 Billion To Expand China Manufacturing

Eli Lilly and Company plans to invest USD 3 billion in China over the next decade to expand its local manufacturing and supply chain capabilities as it prepares for potential demand for new diabetes and obesity treatments.

Manufacturing | 12/03/2026 | By Darshana |  114